The winners of the 2026 ISPE Facility of the Year Awards (FOYA) were officially honored last week at the FOYA Banquet and Awards Celebration during the ISPE Annual Meeting & Expo in Washington D.C. We are proud to jointly celebrate with our partner Bayer the success of the SOLIDA-1 project, which received two FOYA awards in the categories “Operations – Operational Excellence” and “Pharma 4.0™”.
Interview with Glatt Pharmaceutical Services on child-appropriate dosage forms and the future of patient-centred formulations.
At CPHI Milan 2026, Glatt will present integrated particle engineering solutions, combining process technology, CDMO services and engineering expertise from early development to commercial manufacturing.
Glatt unveiled its new spray drying technology – the GSX.Lab – at Interpack during an exciting opening ceremony.
The SOLIDA-1 facility sets new standards for modular, adaptable, and highly automated pharmaceutical manufacturing. As system integrator, Glatt played a key role in the project by delivering and integrating advanced process equipment and intelligent intralogistics solutions, contributing to Bayer’s success at the ISPE Facility of the Year Awards.
Fully automated tablet production: Moving heavy containers and handling materials manually is a thing of the past at Bayer – at least in the new Solida 1 tablet production facility. Here, intralogistics is fully automated. This is made possible by a unique software solution that coordinates the robot-assisted systems for material flow.
Optimize formulations for detergent components, ensure specific functions and protect valuable ingredients.
We are delighted to announce a significant achievement for Glatt: the successful manufacturing of bioprocessing suites for insulin production for a client in Egypt. With the successful Factory Acceptance Test (FAT), this project marks our first venture in the bioprocessing sector outside of Asia, demonstrating our ability to meet diverse market demands while maintaining the highest standards of quality, innovation, and regulatory compliance.
Experience two exciting days with us at the PharmaCongress with interesting presentations on current topics that move the pharmaceutical world. A special highlight is the exciting presentation by Anton Kopitzsch, Glatt Team Lead Automation, and Andreas Bail, Bayer PCT Lead, on April 8 at 13:30: “Design & Implementation of a new highly automated modular OSD production plant at Bayer Leverkusen (Case Study)”.
Together with Rieckermann and joint partners we successfully hosted a seminar from December 3 to 5 at their Shanghai Technology Showcase Center focusing on “Quality by Design: Continuous Manufacturing Processes, In-process and Quality Control Technologies” to share latest technologies and experiences.
You need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from Turnstile to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from reCAPTCHA. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information